Man Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.94M Sell
47,226
-52,962
-53% -$6.66M 0.01% 836
2025
Q1
$11.1M Sell
100,188
-44,976
-31% -$4.97M 0.03% 587
2024
Q4
$19.8M Sell
145,164
-151,015
-51% -$20.6M 0.05% 374
2024
Q3
$34.1M Buy
296,179
+62,954
+27% +$7.25M 0.09% 259
2024
Q2
$32.1M Sell
233,225
-56,536
-20% -$7.78M 0.08% 266
2024
Q1
$40M Sell
289,761
-28,673
-9% -$3.95M 0.1% 209
2023
Q4
$42M Buy
+318,434
New +$42M 0.12% 200
2023
Q3
Sell
-630,747
Closed -$59.5M 199
2023
Q2
$59.5M Buy
+630,747
New +$59.5M 0.18% 122
2023
Q1
Sell
-315,970
Closed -$37.7M 93
2022
Q4
$37.7M Buy
315,970
+210,283
+199% +$25.1M 0.14% 187
2022
Q3
$11.2M Buy
+105,687
New +$11.2M 0.05% 434
2022
Q2
Sell
-247,313
Closed -$23.2M 1001
2022
Q1
$23.2M Buy
247,313
+13,750
+6% +$1.29M 0.08% 278
2021
Q4
$19.9M Buy
+233,563
New +$19.9M 0.06% 373
2021
Q1
Sell
-2,107
Closed -$202K 1945
2020
Q4
$202K Sell
2,107
-186,516
-99% -$17.9M ﹤0.01% 1736
2020
Q3
$18.1M Buy
188,623
+93,819
+99% +$9.02M 0.07% 295
2020
Q2
$11.6M Buy
94,804
+47,147
+99% +$5.75M 0.06% 313
2020
Q1
$4.12M Buy
47,657
+35,019
+277% +$3.03M 0.03% 564
2019
Q4
$1.36M Buy
12,638
+5,099
+68% +$548K ﹤0.01% 1424
2019
Q3
$679K Sell
7,539
-48,564
-87% -$4.37M ﹤0.01% 1507
2019
Q2
$4.74M Sell
56,103
-30,075
-35% -$2.54M 0.02% 965
2019
Q1
$7.59M Sell
86,178
-69,706
-45% -$6.14M 0.03% 695
2018
Q4
$11.1M Buy
155,884
+141,180
+960% +$10.1M 0.05% 419
2018
Q3
$1.81M Sell
14,704
-2,620
-15% -$322K 0.01% 1448
2018
Q2
$1.7M Sell
17,324
-5,125
-23% -$504K 0.01% 1408
2018
Q1
$1.86M Buy
+22,449
New +$1.86M 0.01% 1292